ImmuCell Corporation (ICCC)

5.950 -0.00  -0.00%  May 25, 8:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

ImmuCell Corporation R&D Expense: 0.28M

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

ICCC R&D Expense Rankings

Overall 76th percentile 417 of 1763
Sector 92nd percentile 31 of 413 in Healthcare
Industry 88th percentile 2 of 17 in Diagnostic Substances

ICCC R&D Expense Range, Past 5 Years

Minimum 0.28M Dec 2011
Maximum 0.67M Jun 2011
Average 0.4158M

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

You may also be interested in these ICCC related companies

Display in Live Stream: Done
Options

ICCC News

$ICCC filed latest Quarterly Report http://stks.co/3oQf
about 16 days ago by MarketBrief
$ICCC filed latest Annual Report http://stks.co/362I
about 64 days ago by MarketBrief
$ICCC filed latest Quarterly Report http://stks.co/17F3
about 197 days ago by MarketBrief
Immucell Corp (ICCC) Reports Q2 Loss of $0.09
Aug 15, 8:21AM Street Insider
=&gt; $ICCC $6.97 Tomsche David Scott director P 1,873 @ $6.63 amnt $12,410 proc&#39;d $641 7/12/2011
about 322 days ago by canarionyc
Immucell falls 14.5%
Jul 07, 1:00PM FlyOnTheWall
Quick revisit of the new 52wk high list: $iccc $gco $mstr $zagg $nymt $ful $jva $solr $nzt
about 342 days ago by ivanhoff
$ICCC is a thinster but worth keeping an eye on as it continues to hit new highs in a weak tape
about 342 days ago by sXc_Capital
Immucell rises 15.1%
Jun 09, 1:00PM FlyOnTheWall
NASDAQ 3 biggest advancers: $HOKU 38.32%, $ICCC 26.06%, $DSCO 22.52%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 972 days ago by datajunkies
NASDAQ 3 biggest advancers: $HOKU 38.32%, $ICCC 26.06%, $DSCO 22.52%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 972 days ago by datajunkies
NASDAQ 3 biggest advancers: $HOKU 38.32%, $ICCC 26.06%, $DSCO 22.52%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 972 days ago by datajunkies
NASDAQ 3 biggest advancers: $HOKU 38.32%, $ICCC 26.06%, $DSCO 22.52%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 972 days ago by datajunkies
NASDAQ 3 biggest advancers: $HOKU 85.22%, $ICCC 54.58%, $DSCO 34.23%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 973 days ago by datajunkies

Recent Quotes

Symbol Price Chg Chg % Market Cap
ICCC 5.950 -0.00 -0.00% 17.97M
ICB 17.62 -0.10 -0.54%
ICAD 0.51 +0.03 +6.01% 25.95M
ICA 6.22 +0.19 +3.15% 930.37M
IBOC 18.67 +0.17 +0.92% 1.245B
IBN 30.14 +0.85 +2.92% 16.88B
IBM 196.55 +2.25 +1.16% 225.13B
GTY 16.26 +0.05 +0.31% 541.25M
GTXI 3.14 +0.07 +2.28% 192.80M
GTU 57.54 -0.86 -1.47%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close